Tyrosine Kinase Inhibitors in Glioblastoma: Refining Precision Medicine

In this online CME-certified program, experts discuss recent advances in the use of tyrosine kinase inhibitors to optimize outcomes in patients with glioblastoma. Watch the on-demand Webcast and download the slides from a dynamic CCO symposium to learn more about how to optimize this approach in your clinical practice.
Manmeet S. Ahluwalia, MD, FACP
Rimas V. Lukas, MD
Tom Mikkelson, MD, FRCPC

Downloadable Slidesets

In this downloadable slideset, Rimas V. Lukas, MD, spotlights NTRK fusions and TRK-targeted therapies for patients with GBM.

Rimas V. Lukas, MD Released: November 22, 2019

In this downloadable slideset, Manmeet S. Ahluwalia, MD, FACP, highlights regorafenib in the REGOMA trial and other multiple receptor kinase inhibitors for patients with GBM.

Manmeet S. Ahluwalia, MD, FACP Released: November 22, 2019

In this downloadable slideset, Tom Mikkelsen, MD, FRCPC, examines optimal clinical trial approaches for GBM therapies.

Tom Mikkelson, MD, FRCPC Released: November 22, 2019
Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by an educational grant from
Bayer Healthcare Pharmaceuticals Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.

Continue

More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?